NASDAQ: ALLR
Allarity Therapeutics Inc Stock Ownership - Who owns Allarity Therapeutics?

Insider buying vs selling

Have Allarity Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeremy R. GraffPresident and Chief Development Officer2025-09-3014,613$1.58
$23.09kSell

1 of 1

ALLR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALLR insiders and whales buy or sell their stock.

ALLR Shareholders

What type of owners hold Allarity Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leon Sass6.83%1,086,238$1.31MInsider
Thomas Jensen3.75%596,734$722.05kInsider
Jeremy R. Graff2.40%381,644$461.79kInsider
Jeffrey S. Ervin0.94%150,000$181.50kInsider
Steen Knudsen0.79%124,976$151.22kInsider
Alexander Epshinsky0.53%85,051$102.91kInsider
Gerald W. McLaughlin0.44%70,000$84.70kInsider
Jesper Hoeiland0.16%25,000$30.25kInsider
Duncan Moore0.14%22,672$27.43kInsider
Marie Foegh0.03%3,988$4.83kInsider

1 of 3

ALLR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALLR0.01%16.02%Net Selling
PTN0.00%100.00%Net SellingNet Selling
CMMB0.00%2.89%Net BuyingNet Selling
MRKR0.00%100.00%
LTRN0.02%53.50%Net Buying

Allarity Therapeutics Stock Ownership FAQ

Who owns Allarity Therapeutics?

Allarity Therapeutics (NASDAQ: ALLR) is owned by 0.01% institutional shareholders, 16.02% Allarity Therapeutics insiders, and 83.97% retail investors. Leon Sass is the largest individual Allarity Therapeutics shareholder, owning 1.09M shares representing 6.83% of the company. Leon Sass's Allarity Therapeutics shares are currently valued at $1.31M.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.